DNA Sequencing Market: Technological advancements in DNA sequencing and increase in genome mapping programs globally are factors that are expected to boost the market growth at a CAGR of ~ 17.64 % :

Pune, India, October 2018/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global DNA Sequencing Market.

Market Highlights

DNA sequencing contains information about genetically determined illness and IQ level of human beings. Increasing adoption of precision medicines and increasing use of other applications such as biotechnology, forensic biology, virology, and molecular biology are factors which are driving the growth of this market. The rise in investment in research and development enhances the demand for DNA sequencing and hence helps to increase market growth. The enzymic method for DNA sequencing has been used for genomic research and as accurate results were obtained by this method the demand for DNA sequencing has increased. This demand has driven the development of the second-generation sequencing method.

However, the lack of reimbursement policies in various countries across the world may limit the growth of this market during the forecast period.       

Regional Analysis

The market in the Americas is expected to boost the global DNA sequencing market owing to technological advancements and increasing incidences of genetic disorders among patients. Increasing investments by government organizations in the research and development of DNA sequencing are also boosting the market growth in this region. The European market is expected to be the second-largest due to government funding and support from the healthcare sector coupled with the rising prevalence of the genetic disorder. However, Asia-Pacific is projected to dominate in terms of growth rate over the forecast period owing to the rising investment towards R&D activities and unhealthy lifestyle which are resulting in an increased prevalence of cancer and other disorders. Rising geriatric population and increasing prevalence of tumor among patients in this region have a positive influence on the development of DNA sequencing market in this region.  The Middle East and Africa accounts for the smallest share due to lack of medical technology and poor medical facilities. Emerging economies such as India and China are leading to growth in the demand for DNA sequencing owing to an increasing number of healthcare awareness programs, government investments in healthcare, and favorable healthcare insurance coverage.  

Access Report @ https://www.marketresearchfuture.com/reports/dna-sequencing-market-5774

Segmentation

The global DNA sequencing market has been segmented on the basis of type, product, technology, application, and end-users. On the basis of type, the market is segmented into instruments and consumables services and workflow products. Based on product the market is segmented into sequencing services and sequencing instruments and consumables. Sequencing instruments and consumables are further sub-segmented into two types such as sequencing instruments and consumables by product type and by platform type. Sequencing instruments and consumables by product type are further sub-segmented into consumables, instruments, whereas sequencing instruments and consumables by platform type are further sub-segmented into NGS, sanger, bioinformatics, sample prep kits, and reagents. On the basis of technology, the market is further segmented into semiconductor sequencing, pyrosequencing, sequencing by synthesis, single-molecule real-time sequencing (SMRT), sequencing by ligation (SBL), and other technologies. On the basis of application, the market is further segmented into diagnostics, agriculture and animal research, biomarker discovery, personalized medicine, drug discovery, and other applications. Based on end-user, the market is segmented into research centers and government institutes and academia, biotechnology and pharmaceutical companies, clinics and hospitals, and other end-users.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

Key Players

Some of the key players in the global DNA sequencing market are Perkin Elmer, Roche Holdings AG, Siemens AG, Illumina, Agilent Technologies Inc., Genia Corporation, Oxford Nanopore technologies, Koninklijke Philips N.V., Pacific Biosciences, Johnson & Johnson, Deep Genomics, Inc., Life Technologies, Illumina, Eppendorf, Tecan, and Thermo Scientific, Hamilton Thorne Biosciences, General Electric Company, Siemens Healthineers GmbH, Myriad Genetics, Bayer Corporation, Beckman Coulter, and others.